Two-Year Follow Up of the LATERAL Clinical Trial: A Focus on Adverse Events

BACKGROUND: The LATERAL trial validated the safety and efficacy of the thoracotomy approach for implantation of the HeartWare HVAD System, leading to Food and Drug Administration approval. We sought to analyze 24-month adverse event (AE) rates, including a temporal analysis of the risk profile, asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieselthaler, Georg M., Klein, Liviu, Cheung, Anson W., Danter, Matthew R., Strueber, Martin, Mahr, Claudius, Mokadam, Nahush A., Maltais, Simon, McGee, Edwin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059760/
https://www.ncbi.nlm.nih.gov/pubmed/33866829
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.006912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059760/
https://www.ncbi.nlm.nih.gov/pubmed/33866829
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.006912

Ejemplares similares